A

Alcami

Pharmaceutical and biologics CDMO services

Business Development Associate - CDMO, Pharma Storage

Full-TimePosted on 8/21/2026Deadline 8/21/27
$70k - $85k/yr
Junior
Bachelor's
Remote in USA
RemoteIdeal candidate will be based in Greater Boston or Greater Raleigh area. Up to 10% travel expected.
Sales & Account ManagementSales Development Representative

About the job

Requirements
  • A bachelor's degree in a related field such as Chemistry, Chemical Engineering, or Life Sciences is required.
  • A minimum of 2–3 years of related experience in an inside sales function or experience dealing with customers, preferably in a technical capacity, is required.
  • Knowledge of current Good Manufacturing Practice (cGMP) and the drug development process through coursework or prior work experience is required.
  • Excellent written and verbal communication skills are required.
  • Excellent project management and organizational skills, with the ability to effectively multitask, are required.
  • Strong problem-solving and critical-thinking skills are required.
  • The candidate must be comfortable, willing, and able to make cold calls.
  • The candidate must be able to write coherent emails and messages to communicate effectively with customers.
  • The candidate must be able to persistently follow up with prospects and leads and reach decision-makers while passing gatekeepers.
  • The candidate must have planning and organizational skills to manage competing priorities efficiently.
  • Strong computer skills, including Microsoft Office, customer relationship management (CRM) systems (SFDC/Salesforce.com), and additional lead-generation systems, are required.
  • The candidate must collaborate with cross-functional teams.
  • Proficiency using internet and social media tools to research potential leads is required.
  • The candidate must have a technology orientation and be able to gain proficiency using a customer relationship management system (CRM).
Responsibilities
  • Handle inbound leads from marketing channels, including web forms, trade shows, and email.
  • Use LinkedIn, Global Data, and SFDC to research leads and learn about their budget, buying authority, needs, and timing.
  • Contact assigned leads by email, phone, LinkedIn, and other routes using a call strategy to maximize outreach efficiency.
  • Qualify leads through interactions, record progress in the CRM (SFDC), and use the MAP to track email opens, forwards, and click-throughs.
  • Partner with marketers to develop messaging and on-brand communications for potential customers.
  • Collaborate with the Business Development team to ensure qualified leads are opportunity-ready and high-quality for continued discussion.
  • Conduct proactive targeting campaigns to secure outbound leads, including area and regional targets based on U.S. field sales trips.
  • Follow initial outreach with appropriate legal documents, such as non-disclosure agreements (NDAs), to begin discussions with leads.
  • Collect competitive intelligence through conversations with prospective leads and collect loss and disqualification metrics to improve future success.
  • Assist with trade show events or other marketing efforts as needed.
  • Maintain accurate customer data and updates in the customer relationship management system (Salesforce); serve as a Salesforce power user.
  • Generate timely reports, including activity reports, metrics, sales targets, and forecasts, as requested.
Desired Qualifications
  • Prior pharmaceutical or contract development and manufacturing organization (CDMO) experience is preferred.
  • Prior pharmaceutical or CDMO experience in technical development or manufacturing functions is preferred.

About the company

Alcami is a contract development and manufacturing organization supporting pharmaceutical and biologics companies from early development through commercial production. Services span drug product manufacturing (sterile fill-finish and oral solid dose), analytical and microbiology lab testing, and cGMP storage with validation and environmental monitoring. What sets Alcami apart is its integrated, end-to-end capabilities across the development lifecycle. The goal is to help pharma and biotech partners deliver safe, high-quality therapies to patients.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Pepperell, Massachusetts

Founded

1984

Get referred to Alcami

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Alcami acquired Tjoapack on May 5, 2026, expanding packaging reach into the Netherlands.
  • January 19, 2026 Durham facility purchase deepens biologics capacity for advanced services.
  • Revelio reported 1,038 employees in March 2026, showing hiring despite CEO turnover.

What critics are saying

  • February 6, 2026 FDA 483 at Charleston flagged sterile manufacturing controls and investigations.
  • Tjoapack integration strains management through 2026, with packaging line delivery only in 2027.
  • A sterile quality failure could shut Charleston operations and imperil Alcami's CDMO credibility.

What makes Alcami unique

  • Patrick Walsh keeps Alcami founder-level operator continuity after January 2025 CEO transition.
  • Durham RTP expansion adds fifth GMP fill-finish line and broad biologics analytical capacity.
  • Six-site U.S. GMP storage network gives Alcami integrated storage, testing, and manufacturing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Company News

PR Newswire
Jan 13th, 2025
Alcami Announces Ceo Transition

Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from a proven industry veteran

PR Newswire
Jul 23rd, 2024
Alcami Unveils New Conditions And Services At State-Of-The-Art Pharma Storage Facility In Garner

"Alcami's new facility is well positioned to fill previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services. "The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency."After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami's high-quality, secure GMP storage network to six U.S

Contract Pharma
Dec 15th, 2021
alcami acquires Masy Systems Inc.

Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization ( CDMO ), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services.

PR Newswire
Dec 15th, 2021
AAIPharma Services Corp. acquired Masy Systems Inc. on Dec 15th 21'.

Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Masy Systems Inc. ("Masy" or "Masy BioServices"), a preferred provider of cGMP Biostorage and pharma support services.

Daily Times Chronicle
Dec 1st, 2021
Masy Systems Inc. launches SenseAnywhere modules

Masy BioServices announces the launch of innovative SenseAnywhere modules.

INACTIVE